{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:03:34Z","timestamp":1776139414576,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Programmes that merge management of Human Immunodeficiency Virus (HIV) and tuberculosis (TB) aim to improve HIV\/TB co-infected patients\u2019 access to comprehensive treatment. However, several reports from sub-Saharan Africa (SSA) indicate suboptimal uptake of antiretroviral therapy (ART) even after integration of HIV and TB treatment. This study assessed ART uptake, its barriers and enablers in programmes integrating TB and HIV treatment in SSA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>A systematic review was performed. Seven databases were searched for eligible quantitative, qualitative and mixed-methods studies published from March 2004 through July 2019. Random-effects meta-analysis was used to obtain pooled estimates of ART uptake. A thematic approach was used to analyse and synthesise data on barriers and enablers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 5139 references identified, 27 were included in the review: 23\/27 estimated ART uptake and 10\/27 assessed barriers to and\/or enablers of ART uptake. The pooled ART uptake was 53% (95% CI: 42, 63%) and between-study heterogeneity was high (I<jats:sup>2<\/jats:sup>\u2009=\u200999.71%, p\u2009&lt;\u20090.001). WHO guideline on collaborative TB\/HIV activities and sample size were associated with heterogeneity. There were statistically significant subgroup effects with high heterogeneity after subgroup analyses by region, guideline on collaborative TB\/HIV activities, study design, and sample size. The most frequently described socioeconomic and individual level barriers to ART uptake were stigma, low income, and younger age group. The most frequently reported health system-related barriers were limited staff capacity, shortages in medical supplies, lack of infrastructure, and poor adherence to or lack of treatment guidelines. Clinical barriers included intolerance to anti-TB drugs, fear of drug toxicity, and contraindications to antiretrovirals. Health system enablers included good management of the procurement, supply, and dispensation chain; convenience and accessibility of treatment services; and strong staff capacity. Availability of psychosocial support was the most frequently reported enabler of uptake at the community level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In SSA, programmes integrating treatment of TB and HIV do not, in general, achieve high ART uptake but we observe a net improvement in uptake after WHO issued the 2012 guidelines on collaborative TB\/HIV activities. The recurrence of specific modifiable system-level and patient-level factors in the literature reveals key intervention points to improve ART uptake in these programmes.<\/jats:p>\n                <jats:p><jats:italic>Systematic review registration<\/jats:italic>: CRD42019131933.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-021-00395-3","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T17:02:39Z","timestamp":1637082159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Barriers to and enablers of uptake of antiretroviral therapy in integrated HIV and tuberculosis treatment programmes in sub-Saharan Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-7132","authenticated-orcid":false,"given":"Benjamin Momo","family":"Kadia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Akem","family":"Dimala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah T.","family":"Fongwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"395_CR1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12879-017-2473-y","volume":"17","author":"RO da Silva Escada","year":"2017","unstructured":"da Silva Escada RO, Velasque L, Ribeiro SR, Cardoso SW, Marins LMS, Grinsztejn E, et al. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil\u2014associated factors and causes of death. BMC Infect Dis. 2017;17:373.","journal-title":"BMC Infect Dis"},{"key":"395_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","volume":"15","author":"YD Mukadi","year":"2001","unstructured":"Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001;15:143\u201352.","journal-title":"AIDS"},{"key":"395_CR3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1183\/09031936.00145714","volume":"45","author":"AL Garc\u00eda-Basteiro","year":"2015","unstructured":"Garc\u00eda-Basteiro AL, L\u00f3pez-Varela E, Respeito D, Gonz\u00e1lez R, Naniche D, Manhi\u00e7a I, et al. High tuberculosis burden among people living with HIV in southern Mozambique. Eur Respir J. 2015;45:547\u20139.","journal-title":"Eur Respir J"},{"key":"395_CR4","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Global tuberculosis report. Geneva, Switzerland: WHO; 2018."},{"key":"395_CR5","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Global tuberculosis report. Geneva, Switzerland: WHO; 2015."},{"key":"395_CR6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7196\/SAMJ.7696","volume":"104","author":"R Kaplan","year":"2014","unstructured":"Kaplan R, Caldwell J, Bekker LG, Jennings K, Lombard C, Enarson DA, et al. Integration of TB and ART services fails to improve TB treatment outcomes: comparison of ART\/TB primary healthcare services in Cape Town, South Africa. S Afr Med J. 2014;104:204\u20139.","journal-title":"S Afr Med J"},{"key":"395_CR7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-3156.2008.02189.x","volume":"14","author":"L Cicci","year":"2009","unstructured":"Cicci L, Tumusherure E, Sera D. Integration of TB and HIV interventions in Northern Uganda. Trop Med Int Heal 2009;14:51","journal-title":"Trop Med Int Heal"},{"key":"395_CR8","doi-asserted-by":"crossref","unstructured":"Manjomo RC, Mwagomba B, Ade S, Ali E, Khomani P, Bondwe P, et al. Collaborative activities and treatment\noutcomes in patients with HIV-associated tuberculosis in Viet Nam. Public health action. 2016;I:60\u20135","DOI":"10.5588\/pha.16.0003"},{"key":"395_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2892-9","volume":"18","author":"SE Reid","year":"2018","unstructured":"Reid SE, Harris J, Besa S, Morse J, Smith HJ, Herce ME, et al. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study. BMC Infect Dis. 2018;18:1\u201312.","journal-title":"BMC Infect Dis"},{"key":"395_CR10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/518667","volume":"196","author":"G Friedland","year":"2007","unstructured":"Friedland G, Churchyard GJ, Nardell E. Tuberculosis and HIV coinfection: current state of knowledge and research priorities. J Infect Dis. 2007;196:S1\u20133.","journal-title":"J Infect Dis"},{"key":"395_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1758-2652-9-3-62","volume":"9","author":"SJ Tsiouris","year":"2007","unstructured":"Tsiouris SJ, Gandhi NR, El-Sadr WM, Gerald F. Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics. J Int AIDS Soc. 2007;9:62.","journal-title":"J Int AIDS Soc"},{"key":"395_CR12","volume-title":"Interim Policy on collaborative TB\/HIV activities","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Interim Policy on collaborative TB\/HIV activities. Geneva, Switzerland: WHO; 2004."},{"key":"395_CR13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1473-3099(11)70145-1","volume":"11","author":"J Uyei","year":"2011","unstructured":"Uyei J, Coetzee D, Macinko J, Guttmacher S. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2011;11:855\u201367.","journal-title":"Lancet Infect Dis"},{"key":"395_CR14","volume-title":"Policy on collaborative TB\/HIV activities; Guidelines for national programmes and other stakeholders","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Policy on collaborative TB\/HIV activities; Guidelines for national programmes and other stakeholders. Geneva, Switzerland: WHO; 2012."},{"issue":"1","key":"395_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/QCO.0b013e32835ba8f9","volume":"26","author":"K Naidoo","year":"2013","unstructured":"Naidoo K, Baxter C, Abdool Karim SS. When to start antiretroviral therapy during tuberculosis treatment? Curr Opin Infect Dis. 2013;26(1):35.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"395_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/cid\/ciu283","volume":"59","author":"O Marcy","year":"2014","unstructured":"Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, Borand L, et al. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis. 2014;59(3):435\u201345.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"395_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3851\/IMP2701","volume":"19","author":"A Naidoo","year":"2014","unstructured":"Naidoo A, Naidoo K, Yende-Zuma N, Gengiah TN, Padayatchi N, Gray AL, et al. Changes to antiretroviral drug regimens during integrated TB-HIV treatment: Results of the SAPiT trial. Antivir Ther. 2014;19(2):161\u20139.","journal-title":"Antivir Ther"},{"key":"395_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12879-014-0735-5","volume":"15","author":"JA Crump","year":"2015","unstructured":"Crump JA, Wu X, Kendall MA, Ive PD, Kumwenda JJ, Grinsztejn B, et al. Predictors and outcomes of bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 stride study. BMC Infect Dis. 2015;15:12.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"395_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QAI.0000000000000030","volume":"65","author":"AF Luetkemeyer","year":"2014","unstructured":"Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, et al. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs. J Acquir Immune Defic Syndr. 2014;65(4):423.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"395_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QAI.0000000000000030","volume":"65","author":"AF Luetkemeyer","year":"2013","unstructured":"Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, et al. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE. JAIDS J Acquir Immune Defic Syndr. 2013;65(4):423\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"key":"395_CR21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.5588\/ijtld.10.0741","volume":"15","author":"M Kumwenda","year":"2011","unstructured":"Kumwenda M, Tom S, Chan AK, Mwinjiwa E, Sodhi S, Joshua M, et al. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi. Int J Tuberc Lung Dis. 2011;15:1663\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"395_CR22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.5588\/ijtld.13.0807","volume":"18","author":"MR Patel","year":"2014","unstructured":"Patel MR, Nana M, Yotebieng M, Tabala M, Behets F, Van Rie A. Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection. Int J Tuberc Lung Dis. 2014;18:694\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"395_CR23","unstructured":"CASP Tools & Checklists [Internet]. Critical Appraisal Skills Programme (CASP). [cited 2020 Nov 2]. Available\nfrom: http:\/\/www.casp-uk.net\/casp-tools-checklists"},{"key":"395_CR24","volume-title":"Quality assessment tool for observational cohort and cross-sectional studies","author":"National Heart Lung and Blood Institute","year":"2014","unstructured":"National Heart Lung and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies. Bethesda, MD: National Institutes of Health. Department of Health and Human Services; 2014."},{"key":"395_CR25","first-page":"611","volume":"14","author":"H Huerga","year":"2010","unstructured":"Huerga H, Spillane H, Guerrero W, Odongo A, Varaine F. Impact of introducing human immunodefi ciency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. Int J Tuberc Lung Dis. 2010;14:611\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"key":"395_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5588\/pha.15.0093","volume":"5","author":"A Ndagijimana","year":"2015","unstructured":"Ndagijimana A, Rugigana E, Uwizeye CB, Ntaganira J. One-stop TB-HIV services evaluation in Rwanda: comparison of the 2001\u20132005 and 2006\u20132010 cohorts. Public Heal Action. 2015;5:209\u201313.","journal-title":"Public Heal Action"},{"key":"395_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/j.1365-3156.2011.02848.x\/full","volume":"16","author":"S Phiri","year":"2011","unstructured":"Phiri S, Khan PY, Grant AD, Gareta D, Tweya H, Kalulu M, et al. Integrated tuberculosis and HIV care in a resource-limited setting: experience from the Martin Preuss Centre, Malawi. Trop Med Int Heal. 2011;16:1397\u2013403. https:\/\/doi.org\/10.1111\/j.1365-3156.2011.02848.x\/full.","journal-title":"Trop Med Int Heal"},{"key":"395_CR28","doi-asserted-by":"crossref","unstructured":"Chileshe M, Bond VA. Barriers and outcomes: TB patients co-infected with HIV accessing antiretroviral therapy in rural Zambia. Seeley J, Russell S, Whiteside A, editors. AIDS Care; 2010;22:51\u20139.","DOI":"10.1080\/09540121003617372"},{"key":"395_CR29","doi-asserted-by":"crossref","unstructured":"Levin L, Irving K, Dikgang M, Punwasi J, Isaacs M, Myer L. TB patients\u2019 perspectives on integrated TB\/HIV services in South Africa. Trop Doct 2006;36:173\u20135. http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med5&NEWS=N&AN=16884629","DOI":"10.1258\/004947506777978226"},{"key":"395_CR30","doi-asserted-by":"crossref","unstructured":"Wajanga BMK, Peck RN, Kalluvya S, Fitzgerald DW, Smart LR, Downs JA. Healthcare worker perceived barriers to early initiation of antiretroviral and tuberculosis therapy among Tanzanian inpatients. PLoS One 2014;9:e87584. http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0087584","DOI":"10.1371\/journal.pone.0087584"},{"key":"395_CR31","doi-asserted-by":"crossref","first-page":"e19484","DOI":"10.1371\/journal.pone.0019484","volume":"6","author":"DJ Pepper","year":"2011","unstructured":"Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS ONE. 2011;6:e19484.","journal-title":"PLoS ONE"},{"key":"395_CR32","unstructured":"Nansera D, Bajunirwe F, Kabakyenga J, Asiimwe PKJ, Mayanja-Kizza H. Opportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district. Afr Health Sci 2010;10:312\u20139."},{"key":"395_CR33","doi-asserted-by":"crossref","unstructured":"Tweya H, Ben-Smith A, Kalulu M, Jahn A, Ng\u2019ambi W, Mkandawire E, et al. Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi. BMC Public Health 2014;14:183.","DOI":"10.1186\/1471-2458-14-183"},{"key":"395_CR34","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-10-129","volume":"10","author":"NB Njozing","year":"2010","unstructured":"Njozing NB, Miguel SS, Tih PM, Hurtig AK. Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon. BMC Public Health. 2010;10:129.","journal-title":"BMC Public Health"},{"key":"395_CR35","doi-asserted-by":"crossref","unstructured":"Njozing BN, Edin KE, San Sebastian M, Hurtig AK. Voices from the frontline: counsellors\u2019 perspectives on TB\/HIV collaborative activities in the Northwest Region, Cameroon. BMC Health Serv Res 2011;11:328.","DOI":"10.1186\/1472-6963-11-328"},{"key":"395_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2019-030833","volume":"9","author":"BM Kadia","year":"2019","unstructured":"Kadia BM, Takah NF, Dimala CA, Smith A. Barriers to and enablers of uptake of and adherence to antiretroviral therapy in the context of integrated HIV and tuberculosis treatment among adults in sub-Saharan Africa: a protocol for a systematic literature review. BMJ Open. 2019;9:1\u20137.","journal-title":"BMJ Open"},{"key":"395_CR37","doi-asserted-by":"crossref","first-page":"e46988","DOI":"10.1371\/journal.pone.0046988","volume":"7","author":"B Kerschberger","year":"2012","unstructured":"Kerschberger B, Hilderbrand K, Boulle AM, Coetzee D, Goemaere E, De Azevedo V, et al. The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study. PLoS ONE. 2012;7:e46988.","journal-title":"PLoS ONE"},{"key":"395_CR38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7196\/SAMJ.4621","volume":"100","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Abdool Karim SS, Baxter C, Friedland G, Gengiah T, Gray A, et al. The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis. S Afr Med J. 2010;100:808\u20139.","journal-title":"S Afr Med J"},{"issue":"3","key":"395_CR39","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/S2352-3018(17)30205-9","volume":"5","author":"CC Iwuji","year":"2018","unstructured":"Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2018;5(3):e116\u201325.","journal-title":"Lancet HIV."},{"key":"395_CR40","unstructured":"World Health Organization (WHO). Thirty five countries accounting for more than 90% of the people becoming newly infected with HIV have been designated Fast-Track countries requiring intensified action. WHO HIV policy adoption and implementation status in countries hiv treatment and care. HIV Treat Care Fact Sheet 2018;2016\u20139."},{"key":"395_CR41","volume-title":"Latest HIV estimates and updates on HIV policies uptake, July 2020 Global HIV, Hepatitis and STI Programmes","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Latest HIV estimates and updates on HIV policies uptake, July 2020 Global HIV, Hepatitis and STI Programmes. Geneva, Switzerland: WHO; 2020."},{"issue":"1","key":"395_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-3567-x","volume":"19","author":"ED Chem","year":"2019","unstructured":"Chem ED, Van Hout MC, Hope V. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):1\u20138.","journal-title":"BMC Infect Dis"},{"key":"395_CR43","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1097\/QAI.0000000000000453","volume":"68","author":"SM Peitzmeier","year":"2015","unstructured":"Peitzmeier SM, Grosso A, Bowes A, Ceesay N, Baral SD. Associations of stigma with negative health outcomes for people living with HIV in the Gambia: Implications for key populations. J Acquir Immune Defic Syndr. 2015;68:S146\u201353.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"395_CR44","doi-asserted-by":"crossref","first-page":"e011453","DOI":"10.1136\/bmjopen-2016-011453","volume":"6","author":"S Rueda","year":"2016","unstructured":"Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV\/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453.","journal-title":"BMJ Open"},{"issue":"1","key":"395_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","volume":"17","author":"JC Kane","year":"2019","unstructured":"Kane JC, Elafros MA, Murray SM, Mitchell EMH, Augustinavicius JL, Causevic S, et al. A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries. BMC Med. 2019;17(1):1\u201340.","journal-title":"BMC Med"},{"key":"395_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.16.1.18588","volume":"16","author":"A Gourlay","year":"2013","unstructured":"Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013;16:1\u201321.","journal-title":"J Int AIDS Soc"},{"key":"395_CR47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.socscimed.2018.05.048","volume":"213","author":"S Ahmed","year":"2018","unstructured":"Ahmed S, Autrey J, Katz IT, Fox MP, Rosen S, Onoya D, et al. Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Soc Sci Med. 2018;213:72\u201384.","journal-title":"Soc Sci Med"},{"issue":"10","key":"395_CR48","doi-asserted-by":"crossref","first-page":"e25403","DOI":"10.1002\/jia2.25403","volume":"22","author":"JE Mantell","year":"2019","unstructured":"Mantell JE, Masvawure TB, Mapingure M, Apollo T, Gwanzura C, Block L, et al. Engaging men in HIV programmes: a qualitative study of male engagement in community-based antiretroviral refill groups in Zimbabwe. J Int AIDS Soc. 2019;22(10):e25403.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"395_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-4491-7-31","volume":"7","author":"K Hermann","year":"2009","unstructured":"Hermann K, Van Damme W, Pariyo GW, Schouten E, Assefa Y, Cirera A, et al. Community health workers for ART in sub-Saharan Africa: learning from experience\u2014capitalizing on new opportunities. Hum Resour Health. 2009;7(1):1\u201311.","journal-title":"Hum Resour Health"},{"issue":"9","key":"395_CR50","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/cis1193","volume":"56","author":"MF Franke","year":"2013","unstructured":"Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, et al. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. Clin Infect Dis. 2013;56(9):1319\u201326.","journal-title":"Clin Infect Dis"},{"key":"395_CR51","doi-asserted-by":"crossref","unstructured":"Kredo T, Ford N, Adeniyi FB, Garner P. Decentralising HIV treatment in lower- and middle-income countries.\nCochrane Database Syst. Rev. 2013; 6:CD009987","DOI":"10.1002\/14651858.CD009987.pub2"},{"key":"395_CR52","doi-asserted-by":"crossref","unstructured":"Kredo T, Adeniyi FB, Bateganya M, Pienaar ED. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy. Cochrane Database Syst Rev 2014;7:CD007331.","DOI":"10.1002\/14651858.CD007331.pub3"},{"key":"395_CR53","doi-asserted-by":"publisher","first-page":"e1003646","DOI":"10.1371\/journal.pmed.1003646","volume":"18","author":"I Eshun-Wilson","year":"2021","unstructured":"Eshun-Wilson I, Awotiwon AA, Germann A, Amankwaa SA, Ford N, Schwartz S, et al. Effects of community-based antiretroviral therapy initiation models on HIV treatment outcomes: a systematic review and meta-analysis. PLOS Med. 2021;18:e1003646. https:\/\/doi.org\/10.1371\/journal.pmed.1003646.","journal-title":"PLOS Med"},{"issue":"1","key":"395_CR54","doi-asserted-by":"crossref","first-page":"e0191294","DOI":"10.1371\/journal.pone.0191294","volume":"13","author":"T Gils","year":"2018","unstructured":"Gils T, Bossard C, Verdonck K, Owiti P, Casteels I, Mashako M, et al. Stockouts of HIV commodities in public health facilities in Kinshasa: barriers to end HIV. PLoS ONE. 2018;13(1):e0191294.","journal-title":"PLoS ONE"},{"issue":"1","key":"395_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-016-2345-3","volume":"10","author":"CA Dimala","year":"2017","unstructured":"Dimala CA, Bechem NN, Aroke D, Kadia BM. Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV\/AIDS patients at a major referral centre in South-west Cameroon. BMC Res Notes. 2017;10(1):1\u20136.","journal-title":"BMC Res Notes"},{"key":"395_CR56","first-page":"1","volume":"15","author":"PJ Anku","year":"2020","unstructured":"Anku PJ, Amo-Adjei J, Doku D, Kumi-Kyereme A. Challenges of scaling-up of TB-HIV integrated service delivery in Ghana. PLoS ONE. 2020;15:1\u201314.","journal-title":"PLoS ONE"},{"key":"395_CR57","unstructured":"Mukuye A, Lukoda N. One-stop shopping for TB and HIV services improved initiation of antiretroviral therapy for patients who are co-infected in eastern Uganda. J Int AIDS Soc. A. Mukuye, Management Sciences for Health, Kampala, Uganda. E-mail: mukdre@yahoo.com: International AIDS Society; 2016;19:94\u20135."},{"key":"395_CR58","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S2213-2600(20)30311-8","volume":"8","author":"C Keene","year":"2020","unstructured":"Keene C, Mohr-Holland E, Cassidy T, Scott V, Nelson A, Furin J, et al. How COVID-19 could benefit tuberculosis and HIV services in South Africa. Lancet Respir Med. 2020;8:844\u20136.","journal-title":"Lancet Respir Med"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-021-00395-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T17:03:59Z","timestamp":1637082239000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-021-00395-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1186\/s12981-021-00395-3","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There was no patient or public involvement in the conduct of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}